Patrik Gonçalves Jorge, Reiner Geyer, Rémy Kinj, Luis Schiappacasse, Wendy Jeanneret-Sozzi, Jean Bourhis, Fernanda Herrera, François Bochud, Claude Bailat, Raphaël Moeckli
{"title":"超高剂量率FLASH放射治疗人体临床方案的机器稳定性和剂量学。","authors":"Patrik Gonçalves Jorge, Reiner Geyer, Rémy Kinj, Luis Schiappacasse, Wendy Jeanneret-Sozzi, Jean Bourhis, Fernanda Herrera, François Bochud, Claude Bailat, Raphaël Moeckli","doi":"10.1002/acm2.70102","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The FLASH effect, induced by ultra-high dose rate (UHDR) irradiations, offers the potential to spare normal tissue while effectively treating tumors. It is important to achieve precise and accurate dose delivery and to establish reliable detector systems, particularly for clinical trials needed to help the clinical transfer of FLASH-Radiotherapy (FLASH-RT). However, the use of monitoring chambers with UHDR beams is presently limited, leading to the reliance on passive dosimetry and machine stability.</p>\n </section>\n \n <section>\n \n <h3> Purpose</h3>\n \n <p>This study aimed to investigate the energy and output stability of a UHDR Mobetron (IntraOp, USA) and to compare it with its conventional dose rate (CDR) mode. Furthermore, we assessed the dosimetric accuracy of a human clinical protocol for FLASH-RT.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Over a 26-month duration, we assessed the short- and long-term stability of the output and energy of the Mobetron system. Daily checks were conducted for 9 MeV CDR and UHDR. In parallel, the IMPulse clinical trial involving patients with skin metastases from melanoma was initiated. Prescription doses ranging from 22 to 28 Gy were administered. Pre-, post-, and <i>in vivo</i> dosimetry using alanine and thermoluminescent dosimeters (TLDs) was performed and compared to the prescription doses.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Short-term output fluctuations remained below 0.6 % and 1 % for 9 MeV CDR and UHDR, respectively. Long-term output fluctuations were within 2 % and the long-term energy fluctuations were below 2 mm (R<sub>50</sub>) for both modes. The delivered doses of the IMPulse trial showed deviations below 4 % compared to prescription doses for all patients.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The Mobetron system demonstrated favorable short- and long-term stability. There was a good agreement between the prescribed and the measured dose for the clinical IMPulse trial. The stability of this UHDR machine allows us to effectively conduct human clinical protocols as well as preclinical experiments, even in the absence of a real-time monitoring system.</p>\n </section>\n </div>","PeriodicalId":14989,"journal":{"name":"Journal of Applied Clinical Medical Physics","volume":"26 6","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/acm2.70102","citationCount":"0","resultStr":"{\"title\":\"Machine stability and dosimetry for ultra-high dose rate FLASH radiotherapy human clinical protocol\",\"authors\":\"Patrik Gonçalves Jorge, Reiner Geyer, Rémy Kinj, Luis Schiappacasse, Wendy Jeanneret-Sozzi, Jean Bourhis, Fernanda Herrera, François Bochud, Claude Bailat, Raphaël Moeckli\",\"doi\":\"10.1002/acm2.70102\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>The FLASH effect, induced by ultra-high dose rate (UHDR) irradiations, offers the potential to spare normal tissue while effectively treating tumors. It is important to achieve precise and accurate dose delivery and to establish reliable detector systems, particularly for clinical trials needed to help the clinical transfer of FLASH-Radiotherapy (FLASH-RT). However, the use of monitoring chambers with UHDR beams is presently limited, leading to the reliance on passive dosimetry and machine stability.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Purpose</h3>\\n \\n <p>This study aimed to investigate the energy and output stability of a UHDR Mobetron (IntraOp, USA) and to compare it with its conventional dose rate (CDR) mode. Furthermore, we assessed the dosimetric accuracy of a human clinical protocol for FLASH-RT.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Over a 26-month duration, we assessed the short- and long-term stability of the output and energy of the Mobetron system. Daily checks were conducted for 9 MeV CDR and UHDR. In parallel, the IMPulse clinical trial involving patients with skin metastases from melanoma was initiated. Prescription doses ranging from 22 to 28 Gy were administered. Pre-, post-, and <i>in vivo</i> dosimetry using alanine and thermoluminescent dosimeters (TLDs) was performed and compared to the prescription doses.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Short-term output fluctuations remained below 0.6 % and 1 % for 9 MeV CDR and UHDR, respectively. Long-term output fluctuations were within 2 % and the long-term energy fluctuations were below 2 mm (R<sub>50</sub>) for both modes. The delivered doses of the IMPulse trial showed deviations below 4 % compared to prescription doses for all patients.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>The Mobetron system demonstrated favorable short- and long-term stability. There was a good agreement between the prescribed and the measured dose for the clinical IMPulse trial. The stability of this UHDR machine allows us to effectively conduct human clinical protocols as well as preclinical experiments, even in the absence of a real-time monitoring system.</p>\\n </section>\\n </div>\",\"PeriodicalId\":14989,\"journal\":{\"name\":\"Journal of Applied Clinical Medical Physics\",\"volume\":\"26 6\",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-04-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/acm2.70102\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Applied Clinical Medical Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/acm2.70102\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Clinical Medical Physics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/acm2.70102","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
Machine stability and dosimetry for ultra-high dose rate FLASH radiotherapy human clinical protocol
Background
The FLASH effect, induced by ultra-high dose rate (UHDR) irradiations, offers the potential to spare normal tissue while effectively treating tumors. It is important to achieve precise and accurate dose delivery and to establish reliable detector systems, particularly for clinical trials needed to help the clinical transfer of FLASH-Radiotherapy (FLASH-RT). However, the use of monitoring chambers with UHDR beams is presently limited, leading to the reliance on passive dosimetry and machine stability.
Purpose
This study aimed to investigate the energy and output stability of a UHDR Mobetron (IntraOp, USA) and to compare it with its conventional dose rate (CDR) mode. Furthermore, we assessed the dosimetric accuracy of a human clinical protocol for FLASH-RT.
Methods
Over a 26-month duration, we assessed the short- and long-term stability of the output and energy of the Mobetron system. Daily checks were conducted for 9 MeV CDR and UHDR. In parallel, the IMPulse clinical trial involving patients with skin metastases from melanoma was initiated. Prescription doses ranging from 22 to 28 Gy were administered. Pre-, post-, and in vivo dosimetry using alanine and thermoluminescent dosimeters (TLDs) was performed and compared to the prescription doses.
Results
Short-term output fluctuations remained below 0.6 % and 1 % for 9 MeV CDR and UHDR, respectively. Long-term output fluctuations were within 2 % and the long-term energy fluctuations were below 2 mm (R50) for both modes. The delivered doses of the IMPulse trial showed deviations below 4 % compared to prescription doses for all patients.
Conclusions
The Mobetron system demonstrated favorable short- and long-term stability. There was a good agreement between the prescribed and the measured dose for the clinical IMPulse trial. The stability of this UHDR machine allows us to effectively conduct human clinical protocols as well as preclinical experiments, even in the absence of a real-time monitoring system.
期刊介绍:
Journal of Applied Clinical Medical Physics is an international Open Access publication dedicated to clinical medical physics. JACMP welcomes original contributions dealing with all aspects of medical physics from scientists working in the clinical medical physics around the world. JACMP accepts only online submission.
JACMP will publish:
-Original Contributions: Peer-reviewed, investigations that represent new and significant contributions to the field. Recommended word count: up to 7500.
-Review Articles: Reviews of major areas or sub-areas in the field of clinical medical physics. These articles may be of any length and are peer reviewed.
-Technical Notes: These should be no longer than 3000 words, including key references.
-Letters to the Editor: Comments on papers published in JACMP or on any other matters of interest to clinical medical physics. These should not be more than 1250 (including the literature) and their publication is only based on the decision of the editor, who occasionally asks experts on the merit of the contents.
-Book Reviews: The editorial office solicits Book Reviews.
-Announcements of Forthcoming Meetings: The Editor may provide notice of forthcoming meetings, course offerings, and other events relevant to clinical medical physics.
-Parallel Opposed Editorial: We welcome topics relevant to clinical practice and medical physics profession. The contents can be controversial debate or opposed aspects of an issue. One author argues for the position and the other against. Each side of the debate contains an opening statement up to 800 words, followed by a rebuttal up to 500 words. Readers interested in participating in this series should contact the moderator with a proposed title and a short description of the topic